AIPLA LinkedIn Live: What the 2025 AIPLA Economic Survey Reveals About IP Practice Today
March 12, 2026 12:00 PM to 12:45 PM
Get a preview of the newly released Report of the Economic Survey, one of AIPLA’s most relied-upon benchmarking publications. Our panel will unpack the latest findings on compensation, billing rates, fee structures, and emerging trends shaping the IP profession — plus the story behind the data and what it means for practitioners at all career stages. Bring your questions and get insight straight from the contributors who helped shape the Survey.
Presented by:
Moderator: Meghan Donohoe, AIPLA
Speakers:
Sarah Knight, Talem IP Law
John Gorecki, Anderson Gorecki LLP
Ryan Dean, Umberg Zipser LLP
This event is free and open to all! Join us LIVE on LinkedIn at 12pm ET on March 12.
Submit questions in advance to Ariella Friedman at afriedman@aipla.org.
Add to:
News
-
AIPLA Comments to the Copyright Office on Alternative Fee Structures for Registration
July 6, 2026
Alexandria, VA. June 24, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the U.S. Copyright Office's Notice of Inquiry regarding alternative copyright registration fee structures. -
AIPLA Comments to the Copyright Office on Group Registration of Updates to a News Website
July 6, 2026
Alexandria, VA. June 29, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments supporting the U.S. Copyright Office's proposed expansion of eligibility for group registration of updates to news websites by removing restrictions that exclude subject-specific publications. -
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
.png?sfvrsn=143e8f56_1 "supreme court")
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry.